A novel multi-parameter scoring system for distinguishing sarcoidosis from sputum negative tuberculosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 29, Issue 1, 2012, Pages 11-18

  Li, Q H ^a   Li, Hui Ping ^a   Shen, Y P ^b   Zhao, L ^a   Shen, L ^a   Zhang, Y ^a   Jiang, D H ^c   Baughman, R P ^d  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SOOCHOW UNIVERSITY   (China)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Decision making process; Granulomatous; Sarcoidosis; Scoring system; Tuberculosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GALLIUM CITRATE GA 67;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHI-SQUARE DISTRIBUTION; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84863638721     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003; 361: 1111-8. (Pubitemid 36369566)
2. Hunninghake GW, Costabel U, Ando M, et al. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160: 736-55.
3. Boeck C. Multiple benign sarcoid of the skin. J Cutan Genitourin Dis 1899; 17: 543-50.
4. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 2005; 201: 755-67. (Pubitemid 40395121)
5. Grosser M, Luther T, Müller J, et al. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest 1999; 79 (7): 775-84. (Pubitemid 29344489)
6. Li N, Bajoghli A, Kubba A, Bhawan J. Identification of mycobacterial DNA in cutaneous lesions of sarcoidosis. J Cutan Pathol 1999; 26 (6): 271-8. (Pubitemid 29373924)
7. Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002; 8 (11): 1334-41. (Pubitemid 35334710)
8. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65.
9. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003; 362: 887-99. (Pubitemid 37130100)
10. Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603-62.
11. Sharma OP. Pulmonary sarcoidosis: management. J Postgrad Med 2002; 48: 135-41. (Pubitemid 35012372)
12. Bates JH. Diagnosis of tuberculosis. Chest 1979; 76: 757-63.
13. Wood PR, Jones SL. Diagnosis of tuberculosis. Lancet 2003; 361: 2081-2; author reply 2082-3.
14. Baughman RP, Iannuzzi MC. Diagnosis of sarcoidosis: when is a peek good enough? Chest 2000; 117: 931-2. (Pubitemid 30228343)
15. Sharma OP. Diagnosis of sarcoidosis. Arch Intern Med 1983; 143: 1418-9. (Pubitemid 13067922)
16. Prager E, Wehrschuetz M, Bisail B, et al. Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin 2008; 47 (1): 18-23. (Pubitemid 351272806)
17. Greenland S, Finkle WD. A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol 1995; 142: 1255-64. (Pubitemid 26006424)
18. M. Multivariable analysis: a practical guide for clinicians. 2nd ed. Cambridge, UK: Cambridge University Press, 1999; 99-108.
19. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170: 1324-30. (Pubitemid 39657197)
20. Valeyre D, Soler P, Clerici C, et al. Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 1988; 43: 516-24.
21. Koyama T, Ueda H, Togashi K, Umeoka S, Kataoka M, Nagai S. Radiologic manifestations of sarcoidosis in various organs. Radiographics 2004; 24: 87-104. (Pubitemid 38134596)
22. Anantham D, Ong SJ, Chuah KL, Fook-Chong S, Hsu A, Eng P. Sarcoidosis in Singapore: epidemiology, clinical presentation and ethnic differences. Respirology 2007; 12 (3): 355-60. (Pubitemid 47164777)
23. Bottaro L, Calderan L, Dibilio D, Mosconi E, Maffessanti M. Pulmonary sarcoidosis: atypical HRTC features and differential diagnostic problems. Radiol Med 2004; 107: 273-85. (Pubitemid 38620323)
24. Tobin MJ. Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000. Am J Respir Crit Care Med 2001; 164: 1774-88. (Pubitemid 33152309)
25. Kurdziel KA. The panda sign. Radiology 2000; 215: 884-5. (Pubitemid 30346034)
26. Li WM, Wang SM, Li CY, et al. Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000. Int J Tuberc Lung Dis 2005; 9: 1314-9.
27. Baughman RP. Therapeutic options for sarcoidosis: new and old. Curr Opin Pulm Med 2002; 8: 464-9. (Pubitemid 34836954)
28. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006; 44 (9): 3448-51. (Pubitemid 44413802)
29. Dubaniewicz A, Kämpfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb) 2006; 86 (1): 60-7. (Pubitemid 41799603)
30. Gazouli M, Ikonomopoulos J, Trigidou R, Foteinou M, Kittas C, Gorgoulis V. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of greek patients with sarcoidosis. J Clin Microbiol 2002; 40: 3060-3. (Pubitemid 35284990)
31. Zhou Y, Li HP, Li QH, et al. Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 93-9.
32. Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23 (3): 180-9. (Pubitemid 47596313)
33. Dubaniewicz A, Szczerkowska Z, Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin Proc 2003; 78: 436-42. (Pubitemid 36373945)
34. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, My liwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology 2007; 12 (3): 346-54. (Pubitemid 47164779)
35. Kelly DM, Greene CM, Meachery G, et al. Endotoxin upregulates interleukin-18: potential role for gram-negative colonization in sarcoidosis. Am J Respir Crit Care Med 2005; 172: 1299-307. (Pubitemid 43076569)
36. Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Myśliwski A. Comparative analysis of mycobacterial heat shock proteins-induced apoptosis of peripheral blood mononuclear cells in sarcoidosis and tuberculosis. J Clin Immunol 2006; 26 (3): 243-50. (Pubitemid 43901653)
37. Niimi T, Sato S, Sugiura Y, et al. Transforming growth factor-beta gene polymorphism in sarcoidosis and tuberculosis patients. Int J Tuberc Lung Dis 2002; 6: 510-5. (Pubitemid 34601868)
38. Dubaniewicz A, Dubaniewicz-Wybieralska M, Sternau A, et al. Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis. J Clin Microbiol 2006; 44 (9): 3448-51. (Pubitemid 44413802)
39. Fourie PB, Becker PJ, Festenstein F, et al. Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 116-23. (Pubitemid 28126066)
40. Soto A, Solari L, Agapito J, et al. Development of a clinical scoring system for the diagnosis of smear-negative pulmonary tuberculosis. Braz J Infect Dis 2008; 12: 128-32.
41. Wisnivesky JP, Kaplan J, Henschke C, McGinn TG, Crystal RG. Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med 2000; 160: 2471-6.
42. Muers MF, Middleton WG, Gibson GJ, et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British Thoracic Society Study of Long-Term Corticosteroid Treatment. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 46-56. (Pubitemid 27170555)
43. Wasfi YS, Rose CS, Murphy JR, et al. A new tool to assess sarcoidosis severity. Chest 2006; 129: 1234-45.